Northern Trust’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-150,294
| Closed | -$3.67M | – | 4316 |
|
|
2017
Q4 | $3.67M | Sell |
150,294
-4,132
| -3% | -$79.4K | ﹤0.01% | 2797 |
|
|
2017
Q3 | $2.85M | Sell |
154,426
-1,792
| -1% | -$31K | ﹤0.01% | 2968 |
|
|
2017
Q2 | $2.59M | Buy |
156,218
+46,857
| +43% | +$652K | ﹤0.01% | 3011 |
|
|
2017
Q1 | $1.51M | Buy |
109,361
+9,774
| +10% | +$157K | ﹤0.01% | 3212 |
|
|
2016
Q4 | $1.89M | Buy |
99,587
+3,053
| +3% | +$58.6K | ﹤0.01% | 3119 |
|
|
2016
Q3 | $2.14M | Buy |
96,534
+2,553
| +3% | +$48K | ﹤0.01% | 3038 |
|
|
2016
Q2 | $1.72M | Buy |
93,981
+33,271
| +55% | +$573K | ﹤0.01% | 3127 |
|
|
2016
Q1 | $1.1M | Buy |
60,710
+1,794
| +3% | +$29K | ﹤0.01% | 3221 |
|
|
2015
Q4 | $993K | Buy |
58,916
+110
| +0.2% | +$1.87K | ﹤0.01% | 3331 |
|
|
2015
Q3 | $1.06M | Buy |
58,806
+6,203
| +12% | +$138K | ﹤0.01% | 3294 |
|
|
2015
Q2 | $1.36M | Buy |
52,603
+37,732
| +254% | +$954K | ﹤0.01% | 3224 |
|
|
2015
Q1 | $325K | Buy |
+14,871
| New | +$321K | ﹤0.01% | 3734 |
|
Northern Trust's ENTL Position: Q1 2018 in Review
Northern Trust sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 150,294 shares — an estimated $3.67M sold.
Northern Trust first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $3.67M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.
- Northern Trust reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
- Northern Trust sold 150,294 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $3.67M.
- Northern Trust first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
- Northern Trust's Entellus Medical, Inc. Common Stock position peaked at $3.67M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.
Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.